SARS-CoV-2 Nsp2 recruits GIGYF2 near viral replication sites and supports viral protein production.

Publication date: Jul 19, 2025

The SARS-CoV-2 genome encodes 16 nonstructural proteins (Nsps), with Nsp2 being the least conserved and understood. This study highlights a crucial role for Nsp2 in the early phase of the viral life cycle, particularly its interaction with GIGYF2, which relocates near double-membrane vesicles (DMVs) and enhances viral protein production. Deletion of the Nsp2-coding region from the viral genome led to a drastic reduction in viral RNA synthesis early in infection (3-4 h after infection). Interactome analysis in virus-infected cells identified GIGYF2, a host-encoded translational regulation protein, as a key Nsp2 partner. This interaction was confirmed for both SARS-CoV-1 and SARS-CoV-2. Depletion of GIGYF2 or its cofactor ZNF598 phenocopied the replication defects observed with Nsp2 deletion, suggesting their critical roles in viral reproduction. Upon infection, GIGYF2 and ZNF598 relocate to areas near DMVs, viral replication sites. This relocation does not occur with the Nsp2-deleted virus, indicating Nsp2’s role in directing GIGYF2 to DMVs. Formaldehyde crosslinking and immunoprecipitation sequencing (fCLIP-seq) identified regions within viral RNAs that potentially interact with GIGYF2, including those encoding M and Orf6. Depletion of GIGYF2 resulted in decreased protein expression of M and Orf6. Our findings reveal the function of Nsp2 in supporting viral protein production by exploiting GIGYF2 as a host factor.

Open Access PDF

Concepts Keywords
Depletion Animals
Formaldehyde Carrier Proteins
Genome Carrier Proteins
Immunoprecipitation COVID-19
Recruits GIGYF2 protein, human
HEK293 Cells
Humans
RNA, Viral
RNA, Viral
SARS-CoV-2
Viral Nonstructural Proteins
Viral Nonstructural Proteins
Virus Replication

Semantics

Type Source Name
pathway KEGG Viral replication
disease IDO production
disease IDO role
pathway KEGG Viral life cycle
disease MESH infection
disease IDO host
disease IDO protein
drug DRUGBANK ANX-510
disease IDO replication
disease MESH defects
pathway REACTOME Reproduction
drug DRUGBANK Formaldehyde
drug DRUGBANK Coenzyme M
pathway REACTOME Translation
disease MESH repression
disease MESH viral infection
disease IDO assay
drug DRUGBANK Phosphate ion
drug DRUGBANK Water
drug DRUGBANK Gentian violet cation
drug DRUGBANK Zoledronic acid
disease IDO reagent
drug DRUGBANK Neon
disease IDO cell
drug DRUGBANK Puromycin
drug DRUGBANK Estrone sulfate
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Isoamyl alcohol
drug DRUGBANK Phenol
drug DRUGBANK Urea
pathway REACTOME Digestion
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Abacavir
drug DRUGBANK Trypsin
drug DRUGBANK Flunarizine
disease MESH dissociation
drug DRUGBANK Aspartame
drug DRUGBANK Tromethamine
drug DRUGBANK Glycine
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Deoxycholic Acid
drug DRUGBANK Acetylcholine
drug DRUGBANK Piroxicam
disease MESH SARS CoV 2 infection
pathway KEGG Ribosome
disease MESH uncertainty
disease IDO infectivity
drug DRUGBANK Trestolone
drug DRUGBANK Albendazole
disease MESH Dengue
pathway REACTOME Viral mRNA Translation
pathway REACTOME Mitochondrial biogenesis
disease MESH common cold
disease MESH coronavirus infection
pathway REACTOME Innate Immune System
disease MESH hepatitis
disease MESH flavivirus infection
pathway KEGG Proteasome

Original Article

(Visited 3 times, 1 visits today)